Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CYH
BUYFLAGCommunity Health Systems, Inc. · Healthcare · United States · $385M · Avg Vol: $6M/d
Community Health Systems has strong quality Q69 and value V61, but momentum at M40 is below the calibrated floor. A 22.1% forward-EPS cut is decisively adverse.
COMPANY DESCRIPTION
Community Health Systems, Inc. is one of the largest publicly traded hospital companies in the United States, operating general acute care hospitals and related healthcare services. The company provides a broad range of inpatient and outpatient services across diverse markets. Its extensive network of facilities and commitment to community-based care positions it as a significant provider within the competitive U.S. healthcare landscape.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.2B | 12.5B | 12.6B | 12.5B | 0.7% | 12.3B | 11.5B | 11.7B | -3.2% |
| EPS | 0.35 | -1.02 | -3.90 | 3.81 | 121.6% | 3.25 | — | — | — |
| Shares | 134.7M | 136.8M | 138.9M | 138.6M | +2.9% | 140.9M | — | — | — |
| Debt | 12.4B | 12.2B | 12.1B | 11.0B | -3.8% | 10.8B | — | — | — |
| Equity | -1.4B | -1.4B | -1.9B | -1.4B | — | — | — | — | — |
| Op CF | 300.0M | 210.0M | 480.0M | 543.0M | 21.9% | 126.0M | — | — | — |
| Inv CF | -259.0M | -26.0M | -275.0M | 847.0M | — | — | — | — | — |
| Fin CF | -430.0M | -264.0M | -206.0M | -1.2B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CYH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CYH | Community Health Systems, Inc.(you) | $385M | 78 | BUY |
| CCRN | Cross Country Healthcare, Inc. | $428M | 87 | STRONG BUY |
| GMRS | GMR Solutions Inc. | $701M | 71 | BUY |
| JYNT | The Joint Corp. | $119M | 75 | BUY |
| INNV | InnovAge Holding Corp. | $1.6B | 77 | BUY |
| AIRS | AirSculpt Technologies, Inc. | $325M | 51 | HOLD |
| SRTA | Strata Critical Medical, Inc. | $436M | 45 | HOLD |
| PNTG | The Pennant Group, Inc. | $1.4B | 66 | BUY |
| TOI | The Oncology Institute, Inc. | $498M | 45 | HOLD |
| ASTH | Astrana Health, Inc. | $2.0B | 85 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.6%